to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Will Wang’s works at the intersection of biology and computer science to study how complex systems of cells interact and how these systems contribute to neuromuscular disease -
The Institute plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology -
Patients with an incurable, genetic liver disease have new hope after an animal study showed that a single drug could reverse its effects -
Children's Health
Incurable liver disease may prove curable
Research from Sanford Burnham Prebys has found a drug that can spur liver regeneration in Alagille syndrome -
Children's Health
Childhood cancer trailblazer Lukas Chavez joins Sanford Burnham Prebys
His research tackles the world’s cruelest cancers -
US researchers have discovered a link between protein misfolding and liver cancer, that could help improve gene therapy for haemophilia -
Daiichi Sankyo initiates Phase 2 trial for drug developed with Sanford Burnham Prebys -
In the News
Running in the family: La Jollan completes 50th consecutive Honolulu Marathon as his kids finish their first
To Dr. Jerold Chun, the marathon is a way to honor his father and bring his family together -
A newly discovered link between protein misfolding and liver cancer could help improve gene therapy for hemophilia -
In the News
Inventing the ELISA Test
How a local La Jolla scientist, Dr. Eva Engvall, helped create the technology that allowed us to do at-home Covid-19 testing -
The day included lab tours for prospective graduate students and workshops for local high school students, all from underrepresented backgrounds -
Drug Discovery
Sanford Burnham Prebys announces start of Phase 2 clinical trial of DS-1211 in individuals with pseudoxanthoma elasticum
Daiichi Sankyo initiates Phase 2 trial for drug developed with Sanford Burnham Prebys
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Years in the Making
Yasuyuki Kihara wins a dream award
Research Assistant Professor Yasuyuki Kihara, Ph.D., has won an Eicosanoid Research Foundation (ERF) Young Investigator Award, an award for researchers working in lipid biology.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
